The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects

Opioids exert an analgesic action by mimicking the effects of endogenous neurotransmitter substances in the central nervous system. Opioids are widely used as antitussives, and it is reasonable to assume that endogenous opioids are involved in the control of cough. In order to investigate this hypothesis, a parallel design study was carried out to examine the effects of 50 mg codeine (opioid agonist), 50 mg naltrexone (opioid antagonist) and placebo on capsaicin-induced cough in 80 healthy volunteers (mean age 25 yrs). Volunteers received two capsaicin challenge units (each consisting of five inhalations of different concentrations of capsaicin, 0.00-3.33 x 10(-4) M). On one challenge unit subjects were instructed to suppress cough, and on the other challenge unit subjects coughed freely. Coughs were recorded on a tape cassette player and later played back into a pen recorder to produce integrated sound traces. The number of coughs in the suppression challenge unit was significantly reduced in all three treatment groups compared to that recorded in the non-suppression challenge unit. Comparisons between the three treatment groups showed that there was no statistical difference between the three groups both before and 90 min after treatment for the total coughs in the suppression challenge unit and for the total coughs in the non-suppression challenge unit. These results demonstrate that capsaicin-induced cough can be voluntarily suppressed, but that both suppressed and non-suppressed cough were unaffected by treatment with codeine, naltrexone or placebo. These results do not provide any support for the hypothesis that capsaicin-induced cough is influenced by endogenous opioid substances.

This article has been cited by other articles:

				D. C. Bolser Cough Suppressant and Pharmacologic Protussive Therapy: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 238S - 249S. [Abstract] [Full Text] [PDF]

				P. V. Dicpinigaitis and R. V. Alva Safety of Capsaicin Cough Challenge Testing Chest, July 1, 2005; 128(1): 196 - 202. [Abstract] [Full Text] [PDF]

				S. Hadjikoutis, C.M. Wiles, and R. Eccles Cough in motor neuron disease: a review of mechanisms QJM, September 1, 1999; 92(9): 487 - 494. [Full Text] [PDF]

				A. N. Passannante, M. J. Hazucha, P. A. Bromberg, E. Seal, L. Folinsbee, and G. Koch Nociceptive mechanisms modulate ozone-induced human lung function decrements J Appl Physiol, November 1, 1998; 85(5): 1863 - 1870. [Abstract] [Full Text] [PDF]

				P E M Smith and C M Wiles Cough responsiveness in neurogenic dysphagia J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 385 - 388. [Abstract] [Full Text] [PDF]